These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38504462)

  • 41. Systemic therapy of psoriasis using methotrexate.
    Smith KC
    Skin Therapy Lett; 2000; 6(3):1-2; 5. PubMed ID: 11176041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acute methotrexate toxicity in psoriasis].
    Arévalo-López A
    Gac Med Mex; 1999; 135(5):513-6. PubMed ID: 10596492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative tolerability of systemic treatments for plaque-type psoriasis.
    McClure SL; Valentine J; Gordon KB
    Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low dose methotrexate induced asymptomatic keratinocyte dystrophy in a patient of psoriasis vulgaris.
    Behera B; Kumari R; Gochhait D; Thappa DM
    J Cutan Pathol; 2016 Dec; 43(12):1238-1241. PubMed ID: 27714834
    [No Abstract]   [Full Text] [Related]  

  • 45. [Eventration and methotrexate in psoriasis].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2010 Oct; 137(10):672. PubMed ID: 20932456
    [No Abstract]   [Full Text] [Related]  

  • 46. Exfoliative dermatitis after long-term methotrexate treatment of severe psoriasis.
    Peters T; Theile-Ochel S; Chemnitz J; Söhngen D; Hunzelmann N; Scharffetter-Kochanek K
    Acta Derm Venereol; 1999 Sep; 79(5):391-2. PubMed ID: 10494723
    [No Abstract]   [Full Text] [Related]  

  • 47. Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study.
    Martyn-Simmons CL; Rosenberg WM; Cross R; Wong T; Smith CH; Barker JN
    Br J Dermatol; 2014 Aug; 171(2):267-73. PubMed ID: 24942271
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis.
    Nijsten T; Spuls PI
    Br J Dermatol; 2008 Jul; 159(1):257-8. PubMed ID: 18489593
    [No Abstract]   [Full Text] [Related]  

  • 49. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
    Berends MA; Snoek J; de Jong EM; Van Krieken JH; de Knegt RJ; van Oijen MG; van de Kerkhof PC; Drenth JP
    Liver Int; 2007 Jun; 27(5):639-45. PubMed ID: 17498249
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bullous drug eruption in a patient with psoriasis after a test dose of methotrexate.
    Sako EY; Famenini S; Wu JJ
    J Am Acad Dermatol; 2013 Nov; 69(5):e264-e265. PubMed ID: 24124857
    [No Abstract]   [Full Text] [Related]  

  • 51. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference.
    Kalb RE; Strober B; Weinstein G; Lebwohl M
    J Am Acad Dermatol; 2009 May; 60(5):824-37. PubMed ID: 19389524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methotrexate-induced eruptive lentiginosis in resolving psoriasis: a phenomenon possibly dependent on cytokine modulation.
    Singh S; Beniwal R
    Clin Exp Dermatol; 2019 Jul; 44(5):e212-e213. PubMed ID: 30900774
    [No Abstract]   [Full Text] [Related]  

  • 53. Methotrexate.
    Boffa MJ
    Adv Exp Med Biol; 1999; 455():341-2. PubMed ID: 10599367
    [No Abstract]   [Full Text] [Related]  

  • 54. Alcohol interactions with drugs and its effect on the treatment of skin diseases.
    Zachariae H
    Clin Dermatol; 1999; 17(4):443-5. PubMed ID: 10497730
    [No Abstract]   [Full Text] [Related]  

  • 55. [Serum liver tests in patients treated with methotrexate. A retrospective analysis].
    Correa G H; Paredes S N
    Rev Med Chil; 2007 Aug; 135(8):1002-8. PubMed ID: 17989857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solar burn reactivation reaction: an unusual side effect of methotrexate.
    Kocatürk E; Köklü N; Güngör S; Ulkümen PK; Bahçetepe N; Erhan SŞ
    Photodermatol Photoimmunol Photomed; 2014 Dec; 30(6):338-9. PubMed ID: 24890023
    [No Abstract]   [Full Text] [Related]  

  • 57. Erythema gyratum repens-like eruption occuring in resolving psoriasis during methotrexate therapy.
    Singal A; Sonthalia S; Pandhi D
    Int J Dermatol; 2010 Mar; 49(3):306-7. PubMed ID: 20465670
    [No Abstract]   [Full Text] [Related]  

  • 58. Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis.
    Khan S; Subedi D; Chowdhury MM
    Postgrad Med J; 2006 May; 82(967):353-4. PubMed ID: 16679477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up.
    Zachariae H; Heickendorff L; Søgaard H
    Br J Dermatol; 2001 Jan; 144(1):100-3. PubMed ID: 11167689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
    Jeffes EW; Weinstein GD
    Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.